-transparent.png){kind=logo}
Preliminary data obtained in the ambit of Anturan Reinfarction Italian Study (ARIS) show that, in postmyocardial infarction, reduced platelet survival time occurred in hyperbetalipoproteinemic patients treated with placebo, but not in the group of patients treated with sulfinpyrazone (interaction between treatment and lipemic level is at p approximately equal to 0.1). The sulfinpyrazone effect on platelet survival is probably related to the release reaction inhibition as suggested by our ex vivo results on platelet-bound 14C-serotonin release.
Related Publications
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
April 1977,
The Journal of laboratory and clinical medicine,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
December 1985,
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
July 1974,
The New England journal of medicine,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
January 1977,
Stroke,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
June 1997,
The American journal of cardiology,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
August 1984,
Thrombosis and haemostasis,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
September 2013,
BMJ open,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
January 1979,
Thrombosis research,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
July 1964,
Acta medica Scandinavica,
M Cortellaro, and
C Boschetti, and
G Fassio, and
M Basagni, and
E E Polli
January 2016,
Platelets,
